Benjamin Burnett
Stock Analyst at Wells Fargo
(3.18)
# 2,590
Out of 4,630 analysts
406
Total ratings
46.6%
Success rate
2.5%
Average return
Main Sectors:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Rated: Hold | $19 → $20 | $20.78 | -3.75% | 2 | Aug 7, 2026 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $101 → $93 | $30.98 | +200.19% | 4 | Aug 7, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Hold | $323 → $362 | $360.76 | +0.34% | 7 | Aug 7, 2026 | |
| INSM Insmed | Rated: Buy | $161 → $169 | $131.10 | +28.91% | 9 | Aug 6, 2026 | |
| UTHR United Therapeutics | Rated: Buy | $738 → $700 | $538.84 | +29.91% | 10 | Aug 6, 2026 | |
| MNKD MannKind | Rated: Buy | $14 → $13 | $4.11 | +216.30% | 8 | Aug 5, 2026 | |
| RARE Ultragenyx Pharmaceutical | Rated: Buy | $47 → $45 | $25.91 | +73.68% | 8 | Aug 5, 2026 | |
| CMPS COMPASS Pathways | Maintained: Hold | $13 | $13.54 | -3.99% | 2 | Aug 5, 2026 | |
| KROS Keros Therapeutics | Rated: Buy | $20 → $18 | $11.15 | +61.43% | 5 | Aug 3, 2026 | |
| PTCT PTC Therapeutics | Rated: Buy | $93 → $106 | $73.31 | +44.59% | 7 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $6.10 | +129.51% | 8 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 | $49.17 | +32.19% | 12 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $46.14 | +47.38% | 1 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $11.61 | +37.81% | 1 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $44 | $30.27 | +45.36% | 1 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 | $212.74 | +19.86% | 7 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $90.22 | -31.28% | 6 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $69 | $63.36 | +8.90% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $9 | $5.83 | +54.37% | 5 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $45.49 | +1.12% | 3 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $64 | $205.15 | n/a | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $13 | $2.79 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $7.23 | n/a | 19 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $6.34 | n/a | 33 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $2.01 | n/a | 23 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $3 | $8.45 | n/a | 30 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $3 | $2.80 | n/a | 23 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $92 | $77.33 | n/a | 21 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $0.7095 | n/a | 7 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $49 | $53.52 | n/a | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $64 | $37.02 | n/a | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.0002 | n/a | 15 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $7.49 | n/a | 11 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.9 → $3.6 | $0.112 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.7 → $3 | $76.48 | n/a | 12 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.5 | $35.69 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.7 → $0.16 | $0.000001 | n/a | 9 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $120 | $27.48 | n/a | 2 | Feb 28, 2022 |
Amphastar Pharmaceuticals
Aug 7, 2026
Rated: Hold
Price Target: $19 → $20
Current: $20.78
Upside: -3.75%
Tectonic Therapeutic
Aug 7, 2026
Maintained: Buy
Price Target: $101 → $93
Current: $30.98
Upside: +200.19%
Praxis Precision Medicines
Aug 7, 2026
Maintained: Hold
Price Target: $323 → $362
Current: $360.76
Upside: +0.34%
Insmed
Aug 6, 2026
Rated: Buy
Price Target: $161 → $169
Current: $131.10
Upside: +28.91%
United Therapeutics
Aug 6, 2026
Rated: Buy
Price Target: $738 → $700
Current: $538.84
Upside: +29.91%
MannKind
Aug 5, 2026
Rated: Buy
Price Target: $14 → $13
Current: $4.11
Upside: +216.30%
Ultragenyx Pharmaceutical
Aug 5, 2026
Rated: Buy
Price Target: $47 → $45
Current: $25.91
Upside: +73.68%
COMPASS Pathways
Aug 5, 2026
Maintained: Hold
Price Target: $13
Current: $13.54
Upside: -3.99%
Keros Therapeutics
Aug 3, 2026
Rated: Buy
Price Target: $20 → $18
Current: $11.15
Upside: +61.43%
PTC Therapeutics
Jul 31, 2026
Rated: Buy
Price Target: $93 → $106
Current: $73.31
Upside: +44.59%
Jul 30, 2026
Maintained: Buy
Price Target: $14
Current: $6.10
Upside: +129.51%
Jul 29, 2026
Rated: Buy
Price Target: $65
Current: $49.17
Upside: +32.19%
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $68
Current: $46.14
Upside: +47.38%
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $11.61
Upside: +37.81%
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $44
Current: $30.27
Upside: +45.36%
Jun 10, 2026
Maintained: Buy
Price Target: $255
Current: $212.74
Upside: +19.86%
Jun 4, 2026
Maintained: Buy
Price Target: $62
Current: $90.22
Upside: -31.28%
Jun 1, 2026
Maintained: Buy
Price Target: $69
Current: $63.36
Upside: +8.90%
May 22, 2026
Rated: Buy
Price Target: $9
Current: $5.83
Upside: +54.37%
Apr 22, 2026
Maintained: Buy
Price Target: $46
Current: $45.49
Upside: +1.12%
Apr 1, 2025
Maintained: Buy
Price Target: $78 → $64
Current: $205.15
Upside: n/a
Mar 31, 2025
Maintained: Buy
Price Target: $26 → $13
Current: $2.79
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $7
Current: $7.23
Upside: n/a
Mar 17, 2025
Maintained: Buy
Price Target: $18
Current: $6.34
Upside: n/a
Mar 17, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $2.01
Upside: n/a
Mar 11, 2025
Maintained: Hold
Price Target: $5 → $3
Current: $8.45
Upside: n/a
Mar 6, 2025
Maintained: Hold
Price Target: $5 → $3
Current: $2.80
Upside: n/a
Mar 3, 2025
Maintained: Buy
Price Target: $94 → $92
Current: $77.33
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $80
Current: $0.7095
Upside: n/a
Feb 13, 2025
Maintained: Hold
Price Target: $53 → $49
Current: $53.52
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $66 → $64
Current: $37.02
Upside: n/a
Apr 19, 2024
Maintained: Buy
Price Target: $10
Current: $0.0002
Upside: n/a
Aug 16, 2023
Maintained: Buy
Price Target: $42
Current: $7.49
Upside: n/a
Aug 10, 2023
Maintained: Hold
Price Target: $3.9 → $3.6
Current: $0.112
Upside: n/a
Mar 2, 2023
Maintained: Hold
Price Target: $4.7 → $3
Current: $76.48
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $4.5
Current: $35.69
Upside: n/a
Apr 29, 2022
Downgraded: Hold
Price Target: $4.7 → $0.16
Current: $0.000001
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $84 → $120
Current: $27.48
Upside: n/a